Nan Fung Life Sciences’ Pivotal BioVenture Partners co-led a $35m extension to the cancer therapy developer’s series A round.

Northpond and Deerfield have co-led a $75m series C round for protein analysis system developer Encodia that included GV and Nan Fung Life Sciences.

Nan Fung Group has backed the esports tournament operator’s series B-plus round, which will go toward product development and global expansion.

Singapore Exchange and Tokai Tokyo Financial Holdings both took part in a series A round for iStox, owner of a digitised security offering trading exchange.

The close of the apprenticeship operator's series GV-backed series B round took its total funding to about $64m and follows its opening of a US office.

The Baidu and Legend Holdings-backed intelligent vehicle technology developer pulled in over $62m of funding last year across two rounds.

Yale-linked Vera has rebranded from Trucode Gene Repair and will use the money to move towards clinical trials.

Vera has picked up series C cash from investors including GV and Alexandria Venture Investments to help progress its Merck Group-licensed autoimmune disease drug candidate through clinical trials.

Rich Products, Thai Union and OurCrowd have participated in a new round of convertible note financing for BlueNalu, which is developing lab-grown seafood products.

The Dell and Orr Partners-backed cloud software developer has collected $54m in a round co-led by Greenfield Partners and Jerusalem Venture Partners.